Published in Pneumonol Alergol Pol on January 01, 2004
BRCA1: a novel prognostic factor in resected non-small-cell lung cancer. PLoS One (2007) 1.86
Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung. Clin Cancer Res (2008) 1.62
[Reccomendation of Polish Respiratory Society for palliative care in chronic lung diseases]. Pneumonol Alergol Pol (2012) 1.48
[Medical students' attitudes towards tobacco smoking at the first and sixth year of their studies 2002-2008]. Pneumonol Alergol Pol (2009) 1.42
Analysis of the differences in whole-genome expression related to asthma and obesity. Pol Arch Med Wewn (2015) 1.39
[The effects of pulmonary rehabilitation on the quality of life in patients with COPD]. Pneumonol Alergol Pol (2007) 1.38
Association between sensitization to Aureobasidium pullulans (Pullularia sp) and severity of asthma. Ann Allergy Asthma Immunol (2007) 1.32
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. PLoS One (2008) 1.14
Prisoners' attitudes towards cigarette smoking and smoking cessation: a questionnaire study in Poland. BMC Public Health (2006) 1.13
Patterns of motivations and ways of quitting smoking among Polish smokers: a questionnaire study. BMC Public Health (2008) 0.99
Air humidity may influence the aerosol distribution of normal saline administered by closed or vented nebulizers operated continuously or dosimetrically. J Aerosol Med Pulm Drug Deliv (2009) 0.97
MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC). Lung Cancer (2004) 0.93
[Recommendations of the Polish Society of Lung Diseases for diagnosis and treatment of chronic obstructive pulmonary disease (COPD)]. Pneumonol Alergol Pol (2012) 0.87
Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes. Clin Lung Cancer (2013) 0.86
YKL-40 protein is a marker of asthma. J Asthma (2011) 0.86
Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy. Int Arch Allergy Immunol (2008) 0.86
Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC). J Cancer Res Clin Oncol (2005) 0.86
[Sarcoidosis--clinical features, diagnosis and treatment]. Przegl Lek (2004) 0.85
[Quality of life of patients with asthma which has been well and poorly controlled]. Pneumonol Alergol Pol (2007) 0.84
Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis. Exp Hematol (2011) 0.83
A portable automatic cough analyser in the ambulatory assessment of cough. Biomed Eng Online (2010) 0.83
Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population. BMC Med Genet (2009) 0.83
Late-phase allergic reaction in nasal provocation with fungal allergens. Allergy Asthma Proc (2008) 0.82
Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer. Anticancer Res (2005) 0.82
Chlamydophila pneumoniae, Mycoplasma pneumoniae infections, and asthma control. Allergy Asthma Proc (2011) 0.82
[Invasive aspergillosis of the paranasal sinuses, lung and brain]. Pneumonol Alergol Pol (2008) 0.82
[Polish respiratory society guidelines for chronic obstructive pulmonary disease]. Pneumonol Alergol Pol (2014) 0.81
A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life. Lung Cancer (2002) 0.81
Lack of association between serotonin transporter gene polymorphism 5-HTTLPR and smoking among Polish population: a case-control study. BMC Med Genet (2008) 0.80
Changes in gene expression caused by insect venom immunotherapy responsible for the long-term protection of insect venom-allergic patients. Ann Allergy Asthma Immunol (2011) 0.80
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer (2006) 0.80
[Style of coping with stress and emotional functioning in patients with asthma]. Pneumonol Alergol Pol (2009) 0.80
[Assessment of hemoptysis etiology among patients hospitalized in Pneumonology Departament of Medical University of Gdańsk in the years 1998-2002]. Pol Arch Med Wewn (2005) 0.78
Gene expression analysis in predicting the effectiveness of insect venom immunotherapy. J Allergy Clin Immunol (2010) 0.78
[Lung microangiopathy in diabetes]. Pneumonol Alergol Pol (2009) 0.78
Risk factors for anaphylaxis in patients with mastocytosis. Pol Arch Med Wewn (2015) 0.77
Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol Alergol Pol (2014) 0.77
Gene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy. Clin Transl Allergy (2013) 0.76
Prognostic relevance of altered pRb and p53 protein expression in surgically treated non-small cell lung cancer patients. Oncology (2004) 0.76
[Side effects of specific immunotherapy in patients with hymenoptera venom allergy]. Pneumonol Alergol Pol (2005) 0.76
The angiotensinogen AGT p.M235T gene polymorphism may be responsible for the development of severe anaphylactic reactions to insect venom allergens. Int Arch Allergy Immunol (2010) 0.76
Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer. Acta Oncol (2005) 0.76
Opioid receptor bronchial tree: current science. Curr Opin Support Palliat Care (2014) 0.76
YKL-40 protein correlates with the phenotype of asthma. Lung (2015) 0.76
[Tobacco smoking among the first-year medical students]. Pneumonol Alergol Pol (2006) 0.75
Asthma control uncontrolled. Pol Arch Med Wewn (2015) 0.75
The osteocalcin gene rs1800247 polymorphism in Kashubian population. Rheumatol Int (2012) 0.75
Intima-media thickness in patients with obstructive sleep apnea without comorbidities. Lung (2013) 0.75
Clinical value of conjunctival allergen challenge in diagnosing allergic conjunctivitis related to latex. Int Arch Allergy Immunol (2010) 0.75
Cellular composition of induced sputum in sarcoidosis. Pneumonol Alergol Pol (2013) 0.75
[Addison's diseases caused by adrenal tuberculosis--case report]. Pol Merkur Lekarski (2004) 0.75
Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer. Lung Cancer (2009) 0.75
[Analysis of deaths caused by obstructive pulmonary diseases in Pomerania province in 2001-2004]. Pneumonol Alergol Pol (2007) 0.75
[The prevalence of tobacco smoking among Polish Pallotins priests and seminarians of Seminary in Ołtarzew]. Pneumonol Alergol Pol (2004) 0.75
[Pulmonary actinomycosis - a case report]. Pneumonol Alergol Pol (2012) 0.75
Persistent impact of cigarette smoking on asthma. J Asthma (2008) 0.75
P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Cancer (2004) 0.75
[Coexistence of sarcoidosis with seminoma--a case report]. Pneumonol Alergol Pol (2013) 0.75
Diabetic pulmonary microangiopathy - fact or fiction? Endokrynol Pol (2011) 0.75
[Treatment of pulmonary hypertension]. Wiad Lek (2007) 0.75
Unusual diagnosis hidden by poorly controlled asthma. Kardiol Pol (2017) 0.75
[Assessment of exercise test and bronchial reversibility test as tools for asthma diagnosis in patients with normal spirometry]. Przegl Lek (2006) 0.75
[Alterations of locus P16INK4a/P14ARF in non-small cell lung cancer]. Pneumonol Alergol Pol (2003) 0.75
[Accuracy of spirometry performed by general practitioners and pulmonologists in Pomeranian Region in the "Prevention of COPD" NHS program]. Pneumonol Alergol Pol (2009) 0.75
[Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer]. Pneumonol Alergol Pol (2005) 0.75
[Chronic obstructive pulmonary disease in women]. Pneumonol Alergol Pol (2012) 0.75
[Serum eosinophil cationic protein (ECP) in patients with perennial rhinitis and atopic dermatitis, allergic to house dust mites]. Pol Merkur Lekarski (2005) 0.75
[Latent tetany masked by syndroms of bronchial asthma and depressive syndrome. Case report]. Pneumonol Alergol Pol (2006) 0.75
The negative predictive value of typing safe local anesthetics. Int Arch Allergy Immunol (2013) 0.75
Modern management of symptoms and quality of life. Curr Probl Cancer (2003) 0.75
[Isolated sarcoidosis of upper respiratory tract--a description of 2 cases]. Pneumonol Alergol Pol (2008) 0.75
[Results of treatment for chronic pleural empyema]. Pneumonol Alergol Pol (2003) 0.75
[Serum anti-P53 antibodies (AB-anti-P53) in patients with advanced non-small cell lung cancer (NSCLC)]. Pneumonol Alergol Pol (2002) 0.75
Clinical value of conjunctival allergen challenge in diagnosing allergic conjunctivitis related to latex. J Allergy Clin Immunol (2007) 0.75
Tracheobronchopathia osteochondroplastica—case report and literature review. Pneumonol Alergol Pol (2015) 0.75
[Malignant mesothelioma of the pleura--diagnostic difficulties]. Pol Merkur Lekarski (2004) 0.75
[Hyperlucent lung syndrom caused by pulmonary artery hypoplasia in patient with diagnosed asthma--case report]. Pol Merkur Lekarski (2008) 0.75
Transthoracic lung ultrasonography in pulmonary alveolar proteinosis - case report. Sarcoidosis Vasc Diffuse Lung Dis (2013) 0.75
[The prevalence of serum IgG antibodies against HTLV viruses type I and II in sarcoidosis patients]. Pneumonol Alergol Pol (2002) 0.75
Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin? Int Arch Allergy Immunol (2014) 0.75
[The induced sputum--methodology and clinical usefulness]. Pneumonol Alergol Pol (2006) 0.75
[Chemotherapy of advanced non-small cell lung cancer with the combination of gemcitabine and cisplatin]. Pneumonol Alergol Pol (2002) 0.75
Pregranulomatous phase of sarcoidosis: immunohistochemical diagnosis. Acta Histochem (2005) 0.75
[Diagnosis and treatment of tobacco dependence]. Pneumonol Alergol Pol (2005) 0.75
[Nasal provocation tests with house dust mite in patients with perennial rhinitis]. Otolaryngol Pol (2003) 0.75
[COPD, lung cancer--a common molecular pathway?]. Pneumonol Alergol Pol (2013) 0.75
[Systemic mastocytosis]. Pneumonol Alergol Pol (2005) 0.75